$76.25
0.610.81%
At close: Dec 15, 4:00 PM EST
$76.65
0.400.52%
After Hours: 6:58 PM EST
Comments
Loading...
PTC Therapeutics Stock Guidance | NASDAQ:PTCT | Benzinga
PTC Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/04/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $750.00M | $800.00M | $1.73B | Get Alert |
| 08/07/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $650.00M | $800.00M | $1.74B | Get Alert |
| 05/06/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $650.00M | $800.00M | $872.16M | Get Alert |
| 02/27/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $600.00M | $800.00M | $891.17M | Get Alert |
| 01/13/2025 | PTCT | PTC Therapeutics | FY | 2025 | — | — | — | $600.00M | $800.00M | $963.31M | Get Alert |
| 01/13/2025 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $814.00M | $814.00M | $795.38M | Get Alert |
| 11/07/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $750.00M | $800.00M | $734.43M | Get Alert |
| 08/08/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $700.00M | $750.00M | $749.22M | Get Alert |
| 04/25/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $680.00M | $606.63M | Get Alert |
| 02/29/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $680.00M | $612.29M | Get Alert |
| 01/08/2024 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $946.00M | $946.00M | $936.85M | Get Alert |
| 01/08/2024 | PTCT | PTC Therapeutics | FY | 2024 | — | — | — | $600.00M | $850.00M | $652.89M | Get Alert |
| 10/26/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $938.32M | Get Alert |
| 08/03/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $962.16M | Get Alert |
| 07/19/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $961.42M | Get Alert |
| 04/27/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $866.89M | Get Alert |
| 02/21/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $898.56M | Get Alert |
| 01/09/2023 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $710.00M | $710.00M | $729.36M | Get Alert |
| 01/09/2023 | PTCT | PTC Therapeutics | FY | 2023 | — | — | — | $940.00M | $1.00B | $865.56M | Get Alert |
| 10/27/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $710.00M | $750.00M | $726.44M | Get Alert |
| 08/04/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $722.95M | Get Alert |
| 05/03/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $721.44M | Get Alert |
| 02/22/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $715.53M | Get Alert |
| 01/10/2022 | PTCT | PTC Therapeutics | FY | 2022 | — | — | — | $700.00M | $750.00M | $654.44M | Get Alert |
FAQ
Q
What is the most recent guidance for PTC Therapeutics (PTCT)?
A
There have been no specific sales or earnings guidance reported for PTC Therapeutics in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved